Compass Pathways to Participate in Stifel Virtual CNS Forum
Compass Pathways (Nasdaq: CMPS), a biotechnology company focused on mental health innovation, has announced its upcoming participation in the Stifel Virtual CNS Forum. The company's management will deliver a presentation on March 18th, 2025 at 11:30 am ET.
The presentation will be available through a live audio webcast on the 'Events' page within the Investors section of Compass's website. Interested parties can access a replay of the webcast for up to 30 days after the event.
Compass Pathways (Nasdaq: CMPS), un'azienda biotecnologica focalizzata sull'innovazione nella salute mentale, ha annunciato la sua prossima partecipazione al Stifel Virtual CNS Forum. La direzione dell'azienda terrà una presentazione il 18 marzo 2025 alle 11:30 ora ET.
La presentazione sarà disponibile tramite una diretta audio sul sito web di Compass, nella sezione 'Eventi' all'interno della sezione Investitori. Le parti interessate possono accedere a una registrazione della diretta per un massimo di 30 giorni dopo l'evento.
Compass Pathways (Nasdaq: CMPS), una empresa biotecnológica centrada en la innovación en salud mental, ha anunciado su próxima participación en el Stifel Virtual CNS Forum. La dirección de la empresa realizará una presentación el 18 de marzo de 2025 a las 11:30 am ET.
La presentación estará disponible a través de una transmisión de audio en vivo en la página de 'Eventos' dentro de la sección de Inversores del sitio web de Compass. Las partes interesadas podrán acceder a una repetición de la transmisión durante un máximo de 30 días después del evento.
Compass Pathways (Nasdaq: CMPS), 정신 건강 혁신에 중점을 둔 생명공학 회사가 Stifel Virtual CNS Forum에 참여할 예정이라고 발표했습니다. 회사 경영진은 2025년 3월 18일 오전 11시 30분 ET에 발표를 진행할 것입니다.
발표는 Compass 웹사이트의 투자자 섹션 내 '이벤트' 페이지에서 생중계 오디오 웹캐스트를 통해 제공됩니다. 관심 있는 분들은 이벤트 후 최대 30일 동안 웹캐스트의 재생을 이용할 수 있습니다.
Compass Pathways (Nasdaq: CMPS), une entreprise biotechnologique axée sur l'innovation en santé mentale, a annoncé sa prochaine participation au Stifel Virtual CNS Forum. La direction de l'entreprise fera une présentation le 18 mars 2025 à 11h30 ET.
La présentation sera disponible via un webinaire audio en direct sur la page 'Événements' dans la section Investisseurs du site web de Compass. Les parties intéressées pourront accéder à un replay du webinaire jusqu'à 30 jours après l'événement.
Compass Pathways (Nasdaq: CMPS), ein biotechnologisches Unternehmen, das sich auf Innovationen im Bereich der psychischen Gesundheit konzentriert, hat seine bevorstehende Teilnahme am Stifel Virtual CNS Forum angekündigt. Die Geschäftsführung des Unternehmens wird am 18. März 2025 um 11:30 Uhr ET eine Präsentation halten.
Die Präsentation wird über einen Live-Audio-Webcast auf der 'Events'-Seite im Investorenbereich der Website von Compass verfügbar sein. Interessierte Parteien können bis zu 30 Tage nach der Veranstaltung auf eine Wiederholung des Webcasts zugreifen.
- None.
- None.
A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.
About Compass Pathways
Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the
Compass is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311958977/en/
Enquiries
Media: Media, media@compasspathways.com
Investors: Stephen Schultz, stephen.schultz@compasspathways.com, +1 401 290 7324
Source: Compass Pathways plc
FAQ
When is Compass Pathways (CMPS) presenting at the Stifel Virtual CNS Forum?
How can investors access Compass Pathways' (CMPS) Stifel Forum presentation?
How long will the replay of CMPS's Stifel presentation be available?
What is the focus of Compass Pathways' (CMPS) business?
